cysteine has been researched along with dipyridamole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beisenherz, G; Flanagan, M; Pelzer, H; Watanabe, Y | 1 |
| Becquemont, L; Brinkmann, U; Dubert, L; El-Morabet, H; Funck-Brentano, C; Jaillon, P; Kerb, R; Strabach, S; Trugnan, G; Verstuyft, C | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for cysteine and dipyridamole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for cysteine and dipyridamole
| Article | Year |
|---|---|
Dipyridamole enhances digoxin bioavailability via P-glycoprotein inhibition.
Topics: Adult; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cardiotonic Agents; Cross-Over Studies; Cysteine; Digoxin; Dipyridamole; Enzyme Inhibitors; Female; Genes, MDR; Genotype; Humans; Male; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Reference Values; Threonine | 2003 |
1 other study(ies) available for cysteine and dipyridamole
| Article | Year |
|---|---|
Inhibition of lipid peroxide formation in mitochondria and fatty acid emulsions by 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyimidine.
Topics: Animals; Ascorbic Acid; Cysteine; Depression, Chemical; Dipyridamole; Emulsions; Fatty Acids; Glutathione; In Vitro Techniques; Iron; Lipids; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Peroxides; Phospholipids; Rats; Stimulation, Chemical; Ultraviolet Rays | 1969 |